Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Revisiting the Tax Treatment of Pass-Through Businesses: A Panel Discussion

Revisiting the Tax Treatment of Pass-Through Businesses: A Panel Discussion

Oct 3, 2022 | Events

On October 3, AEI’s Alex Brill and Kyle Pomerleau hosted a panel of experts to discuss the tax treatment of pass-through businesses and opportunities for reform.

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes

Sep 28, 2022 | Op-Eds

In a previous post, we explained how President Joe Biden’s student loan forgiveness plan could result in $4.8 billion in additional state income taxes from borrowers in seven states.

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues

Sep 19, 2022 | Op-Eds

More than 43 million Americans will see their student loan debt partially or completely forgiven under President Biden’s student loan relief plan

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition

Aug 25, 2022 | Interviews

Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to discuss his latest report for CAPD.

New PCMA Podcast Highlights Importance of Prescription Drug Rebates

New PCMA Podcast Highlights Importance of Prescription Drug Rebates

Aug 16, 2022 | Press Releases

“The rebate rule came out of a concern about rising drug prices,” said Brill. “But it is a policy that is chock full of unintended consequences. If it were implemented, we’d have fewer discounts. That’s definitely not going to lower overall spending in the healthcare sector.”

« Older Entries
Next Entries »
  • Analysis (54)
  • Books (3)
  • Commentary (15)
  • Events (22)
  • Interviews (61)
  • News (56)
  • Op-Eds (103)
  • Press Releases (4)
  • Testimony (21)
  • Biosimilars face barriers
    Alex Brill Featured in AxiosJuly 24, 2026
  • Disparate State Impacts and Enormous Cost of a Gas Tax Holiday
    The Disparate State Impacts and Enormous Cost of a Gas Tax HolidayJune 9, 2026
  • Brill discusses tax code and budget challenges
    ‘Facing the Future’: Alex Brill discusses tax code and budget challengesApril 9, 2026
  • Building an Achievable Fiscal Policy
    2026 Portman Center Symposium: Building an Achievable Fiscal PolicyApril 8, 2026
  • Reduced Charitable Giving
    Senator Booker’s Costly Standard Deduction Proposal Would Reduce Charitable GivingApril 7, 2026
  • FDA Continues to Expedite Biosimilar Development
    FDA Continues to Expedite Biosimilar DevelopmentMarch 18, 2026
  • Government’s Drug Negotiation Program
    Diminishing Returns from the Government’s Drug Negotiation ProgramJanuary 29, 2026
  • ACA Tax Credit Extension Matter
    Would Senate Passage of an ACA Tax Credit Extension Matter?January 14, 2026
  • PBMs Pass Through Rebates
    MGA Brief Examines State and Federal PBM MandatesDecember 1, 2025
  • FDA Moves to Facilitate Biosimilar Development
    FDA Moves to Facilitate Biosimilar DevelopmentOctober 30, 2025
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact